Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Index movements reflect changes in component stock prices, earnings, macro data, and capital flows. This overview highlights the main drivers behind daily swings.
18,176 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
May 2026 brings a packed streaming slate as platforms roll out new originals and surprises, shaping market chatter ar...
SoundHound AI's 2026 earnings journey sheds light on how voice AI monetizes across devices. This guide breaks down th...
Investors are watching IonQ as it edges toward scalable quantum systems through a photonic interconnect. This breakth...
Strategy Inc. raised hundreds of millions by selling new common stock to buy bitcoin, while Michael Saylor posted a r...
Federal investigators say encrypted texts reveal Nvidia-linked smuggling patterns tied to China and Russia, highlight...
This in-depth look at Ideal Power's Q1 2026 earnings breaks down the numbers, the growth drivers, and what it means f...
Two tech giants sit at the edge of unprecedented scale. This article weighs Nvidia and Alphabet's growth engines, eva...
As AI reshapes software profits, select lightly priced players with durable moats and capable leadership attract barg...
Wells Fargo agreed to a $110 million discrimination settlement, prompting a cautious but constructive market response...